Medicines have to pass through a rigorous series of clinical trials to prove their efficacy and safety; by bypassing systems that are in place, the manufacturers of counterfeit medicines are not only illegally profiting from others' endeavors--they are also putting patients' lives at risk.

After more than a decade of provocation and international dithering, we must stamp out the Somali pirate havens once and for all.

Frenzy over every detail of WikiLeaks and Julian Assange distracts us from the serious implications of this security breach. The Obama administration must ask hard questions about the alleged Bradley Manning leak or Obama's credibility will be at stake.

The market for counterfeit products is barely understood. Not all counterfeiting is deceptive, so what is the best policy to deal with that reality?

Multilateral organizations in conjunction with the FDA must do more to expose the problem of counterfeit drugs and help countries tighten regulatory controls.

Drugs donated to developing countries are being stolen by criminal groups, which harms patients, encourages criminal networks, and probably leads to dangerous counterfeiting.

US/EU companies that protect their drug brands in turn protect our lives. We need other countries to do more and we need to help them in doing so.

We are at a political impasse in the fight against fake drugs.